Showing 1 - 5 results of 5 for search 'Charles Cleeland', query time: 0.03s
Refine Results
-
1
-
2
-
3
A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors... by Alejandro Zulbaran‐Rojas, Huei‐Kan Lin, Qiuling Shi, Loretta A. Williams, Binsah George, Guillermo Garcia‐Manero, Elias Jabbour, Susan O’Brien, Farhad Ravandi, William Wierda, Zeev Estrov, Gautam Borthakur, Tapan Kadia, Charles Cleeland, Jorge E. Cortes, Hagop Kantarjian
Published 2018-11-01
Article -
4
Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial by Tito R. Mendoza, David S. Hong, Christine B. Peterson, Bettzy Stephen, Ecaterina Dumbrava, Shubbam Pant, Apostolia Maria Tsimberidou, Timothy Anthony Yap, Ajay Sheshadri, Mehmet Altan, Goldy George, Lilibeth Castillo, Enedelia Rodriguez, Jing Gong, Vivek Subbiah, Filip Janku, Siqing Fu, Sarina A. Piha-Paul, Jordi Rodon Ahnert, Daniel D. Karp, Charles Cleeland, Funda Meric-Bernstam, Aung Naing
Published 2022-08-01
Article -
5
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory by Vivek Subbiah, Jing Gong, Siqing Fu, Aung Naing, Shubham Pant, Filip Janku, Mehmet Altan, Kenneth Hess, Ajay Sheshadri, Lilibeth Castillo, Bettzy Stephen, David S Hong, Sarina A Piha-Paul, Tito Mendoza, Goldy George, Enedelia Rodriguez, Christine Peterson, Jordi Rodon Ahnert, Ecaterina Dumbrava, Timonthy A Yap, Apostolia M Tsimberidou, Daniel D Karp, Abdulrazzak Zarifa, Lacey M McQuinn, Charles Cleeland
Published 2020-10-01
Article